Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
24,768,649
-
Share change
-
+50,047
-
Total reported value
-
$2,516,965,895
-
Put/Call ratio
-
144%
-
Price per share
-
$101.61
-
Number of holders
-
264
-
Value change
-
+$4,668,529
-
Number of buys
-
128
-
Number of sells
-
123
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q4 2016
As of 31 Dec 2016,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
264 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,768,649 shares.
The largest 10 holders included
BlackRock Fund Advisors, VANGUARD GROUP INC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, Knott David M, VICTORY CAPITAL MANAGEMENT INC, STATE STREET CORP, WELLS FARGO & COMPANY/MN, CARDINAL CAPITAL MANAGEMENT LLC /CT, OAK RIDGE INVESTMENTS LLC, and BANK OF AMERICA CORP /DE/.
This page lists
264
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.